Jannsen and Nanolek are launching a project for localization of Darzalex®
Janssen, a pharmaceutical company owned by Johnson and Johnson, and a Russian biopharmaceutical company Nanolek have announced the localization of manufacturing of Darzalex®(daratumumab) in Russia, which is used in treatment of multiple myeloma. The battle against malignant hematologic diseases has been a strategic direction that Janssen had been working towards for many years now. Our…